Citigroup
CGEM icon

Citigroup’s Cullinan Oncology CGEM Stock Holding History

Citigroup’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.05M Sell
144,111
-96,346
-40% -$1.24M ﹤0.01% 2656
2025
Q4 		$2.49M Buy
240,457
+133,282
+124% +$1.2M ﹤0.01% 2515
2025
Q3 		$636K Buy
107,175
+80,684
+305% +$591K ﹤0.01% 3454
2025
Q2 		$199K Sell
26,491
-54,509
-67% -$438K ﹤0.01% 4064
2025
Q1 		$613K Buy
81,000
+327
+0.4% +$3.14K ﹤0.01% 3564
2024
Q4 		$983K Buy
80,673
+42,285
+110% +$608K ﹤0.01% 3383
2024
Q3 		$643K Buy
38,388
+16,281
+74% +$289K ﹤0.01% 3569
2024
Q2 		$386K Sell
22,107
-63,467
-74% -$1.35M ﹤0.01% 3549
2024
Q1 		$1.46M Buy
85,574
+75,004
+710% +$1.16M ﹤0.01% 2717
2023
Q4 		$108K Sell
10,570
-12,964
-55% -$115K ﹤0.01% 4176
2023
Q3 		$213K Buy
23,534
+15,308
+186% +$159K ﹤0.01% 3631
2023
Q2 		$88.5K Sell
8,226
-9,013
-52% -$95.7K ﹤0.01% 4303
2023
Q1 		$176K Buy
17,239
+16,113
+1,431% +$178K ﹤0.01% 3791
2022
Q4 		$11.9K Sell
1,126
-207
-16% -$2.52K ﹤0.01% 4789
2022
Q3 		$17K Sell
1,333
-1,790
-57% -$24.1K ﹤0.01% 4793
2022
Q2 		$40K Sell
3,123
-7,634
-71% -$86.6K ﹤0.01% 4630
2022
Q1 		$113K Sell
10,757
-49,921
-82% -$674K ﹤0.01% 4352
2021
Q4 		$936K Buy
60,678
+57,507
+1,814% +$1.15M ﹤0.01% 3327
2021
Q3 		$72K Buy
3,171
+2,304
+266% +$61.6K ﹤0.01% 4548
2021
Q2 		$22K Sell
867
-1,603
-65% -$49.3K ﹤0.01% 5240
2021
Q1 		$103K Buy
+2,470
New +$100K ﹤0.01% 4340

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return